The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis

The objective of this blind, randomized controlled study was to evaluate effect of 12 months alendronate treatment on bone mineral density (BMD) and bone formation, resorption markers in postmenopausal osteoporotic women. Women with BMD values at least 2 standard deviations (SD) below BMD of adult p...

Full description

Bibliographic Details
Published in:Türk Osteoporoz Dergisi
Main Authors: S. Akı, R. G. Gulbaba, N. Eskiyurt
Format: Article
Language:English
Published: Turkish Society of Osteoporosis 2002-03-01
Subjects:
Online Access:http://www.turkosteoporozdergisi.org/article_4172/The-Effect-Of-Alendronate-Treatment-On-Bone-Density-And-Bone-Markers-In-Postmenopausal-Osteoporosis